Wednesday, June 08, 2022 4:08:42 PM
OTCShotCaller
08:05 AM
$RGBP
- Here's what to expect NEXT! You can bet that the recent CNN Interview with Oncologist Dr. Andrea Cercek at Sloan Kettering Cancer Center in New York who conducted the clinical trials on 14 patients with colon cancer by using the check point inhibitor Monoclonal Antibody Dostarlimab with 100% remission in ALL patents within 24 weeks, immediately went GLOBAL! It's the FIRST TIME EVER in the clinical practice of Oncology worldwide! This breakthrough represents the "Paradigm Shift" I've discussed here many times that represents the Future of Medicine, and NOW it's become an astonishing reality! Being a clinical trials physician for 30 years within the Big Pharma sector, I knew this was inevitable! What's also inevitable is every Big Pharma on the planet has heard this news by now and will be racing to grab Check Point Inhibitor Patents from any Biohparmas that have them, in particular those based on mRNA Vaccine, like RGBP. Don't be surprise if Dr Koos gets a call from Eli Lilly!
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM